Phase 1a trial of ABI-H2158 in healthy volunteers

Trial Profile

Phase 1a trial of ABI-H2158 in healthy volunteers

Planning
Phase of Trial: Phase I

Latest Information Update: 07 May 2018

At a glance

  • Drugs ABI-H2158 (Primary)
  • Indications Hepatitis B
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 07 May 2018 According to an Assembly Biosciences media release, this trial is expected to begin in the fourth quarter of 2018.
    • 10 Apr 2018 New trial record
    • 05 Apr 2018 According to an Assembly Biosciences media release, this trial is expected to begin in second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top